Replies to post #88215 on Anavex Life Sciences Corp (AVXL)

[plexrec]

make...logical assumption--many indications where 2-73 will benefit patients !!!!

[Amatuer17]

For me - the approval of grants is a very good news as
- it allows to start a trial in a orphan disease
- the trial is comparatively short and it could indicate efficacy
- ALZ trial improvements are much subjective but Rett improvements are more visible and objective

Efficacy signs in Rett will add to credibility of A2-73 as a drug that is crossing Brain Blood Barrier safely and having meaningful positive impact. It could become for targeting any CNS

That itself will bring more confidence in A2-73 and guide positive sentiment - they can then look at epilepsy etc besides ALZ.

This itself will bring more BP attention much before approval.